Web Exclusives

There is no doubt that flu will return, but we are prepared for it, says Beverly Taylor

Extracting the value from data integration

Has the pandemic created a perfect storm for counterfeit pharmaceuticals?

Enter the Patient Partnership Index 2021 to define the future of patient partnerships

Analysis of how the pharmaceutical sector is viewed through its Environmental, Social and Corporate Governance (ESG) actions indicates that the moment for reputational enhancement might be passing

Sharmila Nebhrajani on the Institute’s new five-year strategy to help bring the benefits of innovations to patients more quickly

Through strong brand communication and design, we are starting to see a new side to pharma and life science and healthcare sectors

Why innovation and continued virtual engagement is key to the future success of the med tech industry

The key three cybersecurity concerns for the pharmaceutical industry in 2021

The next generation of digitised collaborative and shared primary care services

Cost, participation, and virtual trials – the three challenges facing clinical organisations

The need for timely medical communication has never been more important than during this pandemic, where the patient care journey quite often needs to take place outside of the hospital setting

Where will wearables go next with healthcare? And what does this all mean for existing healthcare systems?

Will the UK government’s controversial immigration exemption will be removed from the Data Protection Act? Here’s why it matters

How pharma companies can create digital content that satisfies demand and meets Google’s specific criteria for keeping users safe